Pharmacovigilance in low‐and middle‐income countries: a review with particular focus on Africa
Low‐and middle‐income countries (LMIC) face unique challenges with regard to the
establishment of robust pharmacovigilance systems capable of generating data to inform …
establishment of robust pharmacovigilance systems capable of generating data to inform …
[HTML][HTML] Adverse drug reaction reporting by healthcare providers in sub-Saharan Africa: A scoping review of the challenges faced and the strategies to address the …
E Moyo, P Moyo, D Mangoya, M Imran… - International Journal of …, 2023 - Elsevier
Background Preventable adverse drug reactions (ADR) and adverse events following
immunization (AEFI) are more prevalent in patients of low-and middle-income nations …
immunization (AEFI) are more prevalent in patients of low-and middle-income nations …
Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya's pharmacovigilance database
Poor-quality, substandard and falsified, medicines pose a significant public health threat,
particularly in low-middle-income countries. A retrospective study was performed on Kenya's …
particularly in low-middle-income countries. A retrospective study was performed on Kenya's …
[PDF][PDF] Dobgima John Fonmboh, Banin Andrew Nyuki, et al.(2024) An Overview of Pharmacovigilance Practice and Management in Sub-Saharan African Countries
CN Fokunang, EA Tembe-Fokunang… - Journal of Clinical …, 2024 - researchgate.net
ABSTRACT Most sub-Sahara African countries faced with prolonged resource deficiencies
suffers specific constraints in establishing a functional and operationally-free …
suffers specific constraints in establishing a functional and operationally-free …
Assessment of the Post-Marketing “Drug Ineffective” Reports Received by the Saudi Vigilance System
HJA Khabbaz, TA Alsoaiby… - Journal of …, 2023 - ebooks.manu2sent.com
Aim: Drug Ineffective (DI) reports are Adverse Drug Events (ADE) important for post-
marketing surveillance (PMS). Currently drug safety information from the DI reports received …
marketing surveillance (PMS). Currently drug safety information from the DI reports received …